Evaluating a new hip implant's performance

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study follows a cohort of at least 500 patients undergoing total hip arthroplasty with the Trident II cup to assess implant survival and clinical outcomes. Data will be collected from multiple high-volume centers in Sweden, focusing on clinical parameters and radiographic findings over a period of 10 years. Patients will be evaluated using standardized scores and imaging techniques at various time points to ensure comprehensive monitoring of the implant's performance. The study aims to benchmark these outcomes against established recommendations to determine the implant's effectiveness.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Primary hip replacement
* Eligible for uncemented fixation of the acetabular component
* Suitable for one of the stem designs from Stryker Orthopaedics
* Accepts follow-up according to the study protocol

Exclusion Criteria:

* Difficulties to understand written information due to language problems or other reasons
* Use of augments needed
* Acute hip fracture
* Tumor in the hip joint

Where it's running

• Department of Orthopaedics
  Mölndal, Västra Götaland County, Sweden Recruiting

Study contacts

• Study coordinator: Maziar Mohaddes, MD, PhD
• Email: maziar.mohaddes@gmail.com
• Phone: +46730701147

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Parent group program using the Unified Protocol for teens with autism and anxiety/depression

  This trial tests a parent-guided adaptation of the Unified Protocol to help adolescents with autism and co-occurring anxiety or depression.

  Recruiting Sahlgrenska University Hospital · Gothenburg · NCT07637799

• EUS-guided radiofrequency ablation for pancreatic insulinoma safety and effectiveness

  This project will try EUS-guided radiofrequency ablation (EUS-RFA) to treat people with pathology-confirmed pancreatic insulinoma and compare safety and outcomes to historic surgical patients.

  Recruiting Sahlgrenska University Hospital · Gothenburg · NCT07585032

• Probiotic combination for irritable bowel syndrome

  This trial will test whether a daily probiotic capsule lowers symptom severity and affects gut transit time in adults with IBS.

  Recruiting Sahlgrenska University Hospital · Gothenburg · NCT07584278

• Primary retroperitoneal lymph node surgery versus chemotherapy for good‑prognosis metastatic testicular cancer

  This study will test whether primary RPLND (surgery) instead of standard chemotherapy leads to fewer side effects and better quality of life for men 18 and older with good‑prognosis metastatic testicular cancer.

  Recruiting Sahlgrenska University Hospital · Gothenburg, Göteborg · NCT07498959

• Repeated exams to classify early pulmonary embolism

  This project will test whether doing repeated blood tests, ECGs, and bedside heart ultrasounds during the first 48 hours after pulmonary embolism helps predict who will get worse in adults treated at Sahlgrenska University Hospital.

  Recruiting Sahlgrenska University Hospital · Gothenburg, Region Västra Götaland and 2 other locations · NCT07491094

• Western Sweden Systemic Sclerosis Project

  This project will collect blood, skin and DNA samples from people with systemic sclerosis in Western Sweden to try to find genes, proteins, and immune changes linked to how the disease starts and gets worse.

  Recruiting Sahlgrenska University Hospital · Gothenburg, Sweden · NCT07345052

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.